BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2675888)

  • 1. [Physostigmine--recent pharmacologic data and their significance for practical use].
    Rupreht J; Schneck HJ; Dworacek B
    Anaesthesiol Reanim; 1989; 14(4):235-41. PubMed ID: 2675888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central anticholinergic syndrome (CAS) in anesthesia and intensive care.
    Schneck HJ; Rupreht J
    Acta Anaesthesiol Belg; 1989; 40(3):219-28. PubMed ID: 2683549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physostigmine salicylate as an antidote.
    Daunderer M
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):523-35. PubMed ID: 7228447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy--physostigmine administered post-operatively].
    Haase U; Rundshagen I
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Mar; 42(3):188-9. PubMed ID: 17366438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physostigmine for the immediate treatment of a patient with the central anticholinergic syndrome induced by cocaine cut with atropine].
    Ridder WP; Klimek M; Rupreht J
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1701-3. PubMed ID: 16104118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blinded trial.
    Funk W; Hollnberger H; Geroldinger J
    Eur J Anaesthesiol; 2008 Jan; 25(1):37-42. PubMed ID: 17655781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physostigmine reversal of central anticholinergic syndrome induced by midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine or by atropine/promethazine/pethidine for premedication? (author's transl)].
    Jost U; Schmid A; Ruppert M
    Anaesthesist; 1982 Jan; 31(1):21-4. PubMed ID: 6896119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physostigmine: is there a role for this antidote in pediatric poisonings?
    Frascogna N
    Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central anticholinergic syndrome during postoperative period].
    Rupreht J; Dworacek B
    Ann Fr Anesth Reanim; 1990; 9(3):295-304. PubMed ID: 2196841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of vigilance in the postanesthetic phase using physostigmine].
    Schneck HJ; von Hundelshausen B; Tempel G; Brosch R
    Anaesthesist; 1985 Sep; 34(9):456-61. PubMed ID: 3909841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative routine use of physostigmine on vigilance, cardiovascular parameters and need of analgesics].
    Latasch L; Müller B; Freye E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Aug; 38(8):528-37. PubMed ID: 12905110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Central anticholinergic syndrome and apnea after general anaesthesia. A rare manifestation of the central anticholinergic syndrome].
    Senne I; Zourelidis C; Irnich D; Kurz M; Hummel T; Zwissler B
    Anaesthesist; 2003 Jul; 52(7):608-11. PubMed ID: 12898046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensive care of delirium syndromes].
    Zielmann S; Petrow H; Walther P; Henze T
    Anaesthesiol Reanim; 2003; 28(1):8-12. PubMed ID: 12666506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ketamine racemate versus S-(+)-ketamine with or without antagonism with physostigmine. A quantitative EEG study on volunteers].
    Engelhardt W; Stahl K; Marouche A; Hartung E; Dierks T
    Anaesthesist; 1994 Nov; 43 Suppl 2():S76-82. PubMed ID: 7840418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analgesia and sedation to supplement incomplete regional anesthesia].
    Wresch KP
    Anaesthesist; 1995 Dec; 44 Suppl 3():S580-7. PubMed ID: 8592970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic modification of vigilance in the postnarcotic phase-- naloxone or physostigmine?].
    Schneck HJ; Tempel G; von Hundelshausen B
    Anasth Intensivther Notfallmed; 1988 Aug; 23(4):209-13. PubMed ID: 3052153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal from high-dose tranylcypromine.
    Eyer F; Jetzinger E; Pfab R; Zilker T
    Clin Toxicol (Phila); 2008 Mar; 46(3):261-3. PubMed ID: 18344110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine treatment in various drug-induced intoxications.
    Nilsson E
    Ann Clin Res; 1982 Aug; 14(4):165-72. PubMed ID: 7168546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine: going ... going ... gone? Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine.
    Martin B; Howell PR
    Eur J Anaesthesiol; 1997 Jul; 14(4):467-70. PubMed ID: 9253580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil (Ro 15-1788) and physostigmine.
    Lauven PM; Stoeckel H
    Resuscitation; 1988; 16 Suppl():S41-8. PubMed ID: 2849177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.